LBA73 Study EV-103 Cohort K: Antitumor activity of enfortumab vedotin (EV) monotherapy or in combination with pembrolizumab (P) in previously untreated cisplatin-ineligible patients (pts) with locally advanced or metastatic urothelial cancer (la/mUC)
Jonathan E. Rosenberg,M. Milowsky,Chethan Ramamurthy,Nataliya Mar,Rana R. McKay,Terence W. Friedlander,C. Ferrario,Sergio Bracarda,Saby George,Helen Moon,Daniel M. Geynisman,Daniel P. Petrylak,Delphine Borchiellini,Earle F. Burgess,J.P. Maroto Rey,A-S. Carret,Yao Yu,Maria Guseva,Blanca Homet Moreno,Peter H. O’Donnell
不配.
模糊中正
不安青牛
杳鸢
pluto
尊敬的金针菇
跳跃仙人掌
无名老大
yar
南风
方羽
嗯哼
36456657
十七
VDC
tuanheqi
pcr163
iNk
猪猪hero
我是站长才怪
皖公网安备34019202002308
